Rhenman & Partners Asset Management Ab Vericel Corp Transaction History
Rhenman & Partners Asset Management Ab
- $766 Million
- Q2 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Vericel Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 58,000 shares of VCEL stock, worth $1.95 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
58,000Holding current value
$1.95 Million% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
293Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$271 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$120 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$94.5 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$82.8 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$81.8 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.58B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...